Table 2.
Authors | Patients | Results and Conclusions |
---|---|---|
Qureshi AI et al. Thromb Res. 2015;136:315–318. | 178 of 1,257 women (14.2%) with SCD used oral contraceptives. | The four fold higher risk of incidence of stroke associated with use of oral contraceptives in women with SCD can be mitigated by controlling other cardiovascular risk factors. |
Whaley NS et al. Blood.2015;126: 3263. | 54 women with SCD median age 35years completed a self-administered electronic survey. | 55% had unintended pregnancy; one third did not use a birth control method at last intercourse. Most common contraceptive methods: surgical sterilization (30%), condoms (30%) and DMPA (9%). Women were more likely to use estrogen-containing methods (6%) than highly effective long-acting methods like intrauterine devices or contraceptive implants (3%). |
Carvalho NS et al. J Obstet Gynaecol. 2017; 37:74–77. | 54 sexually active women with SCD with. mean age 32 ±11.2 years. 50% had kidney disease and 17% had thrombosis. | Over 80% had used some form of contraception mostly combined hormonal contraceptive (52%) or progestin-only contraceptives (46%). No association was found between the use of combined oral contraceptive pill and major complications. |
Day ME et al. South Med J. 2019; 112:174–179. | A paper survey at two academic medical centers in 103 SCD women aged 10 to 55 years. | Of 103 women, 53 (51.5%) used contraception, with DMPA injections and condoms being the most common. |